| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $39.4M | +66.3% |
| SG&A Expense | $12.1M | +18.6% |
| Operating Income | -$51.5M | -51.9% |
| Pre-tax Income | -$47.9M | -64.8% |
| Income Tax | -$30K | +6.3% |
| Net Income | -$47.9M | -64.8% |
| EPS (Basic) | -$0.47 | -62.1% |
| EPS (Diluted) | -$0.47 | -62.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.1M | +5.2% |
| Short-term Investments | $73.5M | +45.4% |
| Current Assets | $109.4M | +25.0% |
| Total Assets | $110.9M | +24.0% |
| Current Liabilities | $10.5M | +80.4% |
| Total Liabilities | $11.3M | +64.2% |
| Stockholders' Equity | $99.6M | +20.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.3M | -20.6% |
| Capital Expenditures | $35K | -74.5% |
| Investing Cash Flow | -$21.5M | -136.2% |
| Financing Cash Flow | $61.5M | +877.3% |
| Free Cash Flow | -$38.3M | -20.2% |